Synovial tissue features associated with poor prognosis in inflammatory arthritis

Abstract Background Inflammatory arthritis encompasses a group of immune-mediated diseases characterized by chronic joint inflammation. Despite having pathogenic mechanisms in common, the prognosis of rheumatoid arthritis (RA), psoriatic arthritis (PsA), and undifferentiated arthritis (UA) could be...

Full description

Bibliographic Details
Main Authors: Ana Belén Azuaga, Andrea Cuervo, Raquel Celis, Beatriz Frade-Sosa, Juan C. Sarmiento-Monroy, Virginia Ruiz-Esquide, José A. Gómez-Puerta, Raimon Sanmartí, Julio Ramírez
Format: Article
Language:English
Published: BMC 2024-01-01
Series:Arthritis Research & Therapy
Subjects:
Online Access:https://doi.org/10.1186/s13075-023-03255-9
_version_ 1797355578010370048
author Ana Belén Azuaga
Andrea Cuervo
Raquel Celis
Beatriz Frade-Sosa
Juan C. Sarmiento-Monroy
Virginia Ruiz-Esquide
José A. Gómez-Puerta
Raimon Sanmartí
Julio Ramírez
author_facet Ana Belén Azuaga
Andrea Cuervo
Raquel Celis
Beatriz Frade-Sosa
Juan C. Sarmiento-Monroy
Virginia Ruiz-Esquide
José A. Gómez-Puerta
Raimon Sanmartí
Julio Ramírez
author_sort Ana Belén Azuaga
collection DOAJ
description Abstract Background Inflammatory arthritis encompasses a group of immune-mediated diseases characterized by chronic joint inflammation. Despite having pathogenic mechanisms in common, the prognosis of rheumatoid arthritis (RA), psoriatic arthritis (PsA), and undifferentiated arthritis (UA) could be different regarding progression to chronic, to erosive, or to self-limited disease. Our aim was to evaluate the potential association of synovial tissue (ST) inflammatory cell infiltrate, the presence of ectopic lymphoid neogenesis (LN +) structures, and poor prognosis factors (PPF) in patients with RA, PsA, and UA. Methods We conducted a retrospective study including patients with active arthritis (RA, PsA, UA) who had ST obtained by rheumatological arthroscopy or ultrasound-guided biopsy. Clinical, demographic, and immunohistochemical data of the synovium was evaluated. Patients with biological therapy at the time of synovial biopsy were excluded. PPF in patients with RA and UA were defined by the presence of anti-cyclic citrullinated peptide antibodies and/or rheumatoid factor, development of bone erosions, or requirement of biological therapy during the follow-up. PPF in patients with PsA were defined as the presence of high levels of acute-phase reactants (ESR/CRP), dactylitis or nail involvement at the time of biopsy, development of bone erosion, or requirement of biological therapy during the follow-up. Results A total of 88 patients were included: 26 RA, 33 PsA, and 29 UA. All patients were followed up for 5 years after the biopsy. Fourteen (53.84%) RA patients had PPF, and 17 (65.38%) had LN + . LN + was associated with PPF (p 0.038) and biologic therapy initiation (p 0.018). A total of 14 (43.75%) PsA patients had PPF. CD15 infiltrate (410.68 [SD 477.63] cells/mm2) was associated with PPF (p 0.008) in PsA patients. Sixteen (55.17%) patients with UA had PPF, and 13 (44.82%) had LN + . In this group, synovial CD68 + macrophages cells density was negatively correlated with DAS28-CRP (r =  − 0.346, p 0.042). Conclusions The presence of LN + and higher CD15 + polymorphonuclear cells infiltrate was associated with PPF in RA and PsA, respectively. No associations were found for UA. These findings suggest a great heterogeneity of the ST features and its pathogenic implications in the subtypes of inflammatory arthritis.
first_indexed 2024-03-08T14:14:09Z
format Article
id doaj.art-65f44a5fd44b4e708acc97ae275226ac
institution Directory Open Access Journal
issn 1478-6362
language English
last_indexed 2024-03-08T14:14:09Z
publishDate 2024-01-01
publisher BMC
record_format Article
series Arthritis Research & Therapy
spelling doaj.art-65f44a5fd44b4e708acc97ae275226ac2024-01-14T12:31:28ZengBMCArthritis Research & Therapy1478-63622024-01-012611810.1186/s13075-023-03255-9Synovial tissue features associated with poor prognosis in inflammatory arthritisAna Belén Azuaga0Andrea Cuervo1Raquel Celis2Beatriz Frade-Sosa3Juan C. Sarmiento-Monroy4Virginia Ruiz-Esquide5José A. Gómez-Puerta6Raimon Sanmartí7Julio Ramírez8Rheumatology Department, Hospital Clinic of BarcelonaRheumatology Department, Hospital General de GranollersRheumatology Department, Hospital Clinic of BarcelonaRheumatology Department, Hospital Clinic of BarcelonaRheumatology Department, Hospital Clinic of BarcelonaRheumatology Department, Hospital Clinic of BarcelonaRheumatology Department, Hospital Clinic of BarcelonaRheumatology Department, Hospital Clinic of BarcelonaRheumatology Department, Hospital Clinic of BarcelonaAbstract Background Inflammatory arthritis encompasses a group of immune-mediated diseases characterized by chronic joint inflammation. Despite having pathogenic mechanisms in common, the prognosis of rheumatoid arthritis (RA), psoriatic arthritis (PsA), and undifferentiated arthritis (UA) could be different regarding progression to chronic, to erosive, or to self-limited disease. Our aim was to evaluate the potential association of synovial tissue (ST) inflammatory cell infiltrate, the presence of ectopic lymphoid neogenesis (LN +) structures, and poor prognosis factors (PPF) in patients with RA, PsA, and UA. Methods We conducted a retrospective study including patients with active arthritis (RA, PsA, UA) who had ST obtained by rheumatological arthroscopy or ultrasound-guided biopsy. Clinical, demographic, and immunohistochemical data of the synovium was evaluated. Patients with biological therapy at the time of synovial biopsy were excluded. PPF in patients with RA and UA were defined by the presence of anti-cyclic citrullinated peptide antibodies and/or rheumatoid factor, development of bone erosions, or requirement of biological therapy during the follow-up. PPF in patients with PsA were defined as the presence of high levels of acute-phase reactants (ESR/CRP), dactylitis or nail involvement at the time of biopsy, development of bone erosion, or requirement of biological therapy during the follow-up. Results A total of 88 patients were included: 26 RA, 33 PsA, and 29 UA. All patients were followed up for 5 years after the biopsy. Fourteen (53.84%) RA patients had PPF, and 17 (65.38%) had LN + . LN + was associated with PPF (p 0.038) and biologic therapy initiation (p 0.018). A total of 14 (43.75%) PsA patients had PPF. CD15 infiltrate (410.68 [SD 477.63] cells/mm2) was associated with PPF (p 0.008) in PsA patients. Sixteen (55.17%) patients with UA had PPF, and 13 (44.82%) had LN + . In this group, synovial CD68 + macrophages cells density was negatively correlated with DAS28-CRP (r =  − 0.346, p 0.042). Conclusions The presence of LN + and higher CD15 + polymorphonuclear cells infiltrate was associated with PPF in RA and PsA, respectively. No associations were found for UA. These findings suggest a great heterogeneity of the ST features and its pathogenic implications in the subtypes of inflammatory arthritis.https://doi.org/10.1186/s13075-023-03255-9Synovial tissuePoor prognosis factorRheumatoid arthritisPsoriatic arthritisUndifferentiated arthritis
spellingShingle Ana Belén Azuaga
Andrea Cuervo
Raquel Celis
Beatriz Frade-Sosa
Juan C. Sarmiento-Monroy
Virginia Ruiz-Esquide
José A. Gómez-Puerta
Raimon Sanmartí
Julio Ramírez
Synovial tissue features associated with poor prognosis in inflammatory arthritis
Arthritis Research & Therapy
Synovial tissue
Poor prognosis factor
Rheumatoid arthritis
Psoriatic arthritis
Undifferentiated arthritis
title Synovial tissue features associated with poor prognosis in inflammatory arthritis
title_full Synovial tissue features associated with poor prognosis in inflammatory arthritis
title_fullStr Synovial tissue features associated with poor prognosis in inflammatory arthritis
title_full_unstemmed Synovial tissue features associated with poor prognosis in inflammatory arthritis
title_short Synovial tissue features associated with poor prognosis in inflammatory arthritis
title_sort synovial tissue features associated with poor prognosis in inflammatory arthritis
topic Synovial tissue
Poor prognosis factor
Rheumatoid arthritis
Psoriatic arthritis
Undifferentiated arthritis
url https://doi.org/10.1186/s13075-023-03255-9
work_keys_str_mv AT anabelenazuaga synovialtissuefeaturesassociatedwithpoorprognosisininflammatoryarthritis
AT andreacuervo synovialtissuefeaturesassociatedwithpoorprognosisininflammatoryarthritis
AT raquelcelis synovialtissuefeaturesassociatedwithpoorprognosisininflammatoryarthritis
AT beatrizfradesosa synovialtissuefeaturesassociatedwithpoorprognosisininflammatoryarthritis
AT juancsarmientomonroy synovialtissuefeaturesassociatedwithpoorprognosisininflammatoryarthritis
AT virginiaruizesquide synovialtissuefeaturesassociatedwithpoorprognosisininflammatoryarthritis
AT joseagomezpuerta synovialtissuefeaturesassociatedwithpoorprognosisininflammatoryarthritis
AT raimonsanmarti synovialtissuefeaturesassociatedwithpoorprognosisininflammatoryarthritis
AT julioramirez synovialtissuefeaturesassociatedwithpoorprognosisininflammatoryarthritis